RestoreSensor® Neurostimulator – The Choice of Continuous Motion

Overview

RestoreSensor™ represents the next generation of neurostimulators for chronic pain, able to sense posture change and automatically adapt stimulation accordingly, giving chronic pain patients the choice of continuous motion with their neurostimulation therapy.

RestoreSensor_eu_image

The world's first and only neurostimulator to automatically adapt stimulation during position change.

Neurostimulation for the treatment of chronic back and leg pain is clinically proven to provide effective and sustained pain relief 1-4, decrease use of opiate analgesics1,3,4, and improve quality of life2-6 and functional ability2,4-6.

How it works

The choice of continuous motion

RestoreSensor™’s exclusive AdaptiveStim™ technology listens and learns from the individual patient’s stimulation needs, then responds by automatically adapting settings each time the patient changes position. A recording memory mode remembers these changes for the future. The result for patients is a therapy which integrates more fully into daily life and movement.

View a short annimation to help explain how it works


 

Bringing objective data to clinicians

While RestoreSensor is automatically adapting to therapy based on patient activity, it is also registering this activity, which gives clinicians new, objective insights into how patients are responding to neurostimulation therapy over time.

Size & placement:

The device is not shown actual size.
Height: 54.0 mm
Width: 54.0 mm
Depth: 9.0 mm

Body Placement

The neurostimulator is usually implanted in the abdomen or buttock. You and your doctor will work together to determine the most appropriate and comfortable placement for you.

1. North RB, Kidd DH, Farrokhi F, et al. (2005) Spinal cord stimulation versus repeated lumbosacral spine surgery for chronic pain: a randomized, controlled trial. Neurosurg; 56: 98–106.
2. Kumar K, Taylor RS, Jacques L, et al. (2007) Spinal cord stimulation versus conventional medical management for neuropathic pain: a multicenter randomised controlled trial in patients with failed back surgery syndrome. Pain; 132: 179–188.
3. Kemler MA, De Vet HCW, Barendse GAM, et al. (2004) The effect of spinal cord stimulation in patients with chronic reflex sympathetic dystrophy: two years’ follow-up of the randomized controlled trial. Ann Neurol; 55: 13–18.
4. Taylor RS. (2006) Spinal cord stimulation in Complex Regional Pain Syndrome and Refractory Neuropathic Back and Leg Pain/Failed Back Surgery Syndrome: results of a systematic review and meta-analysis. J Pain Symptom Manage; 31: S13–S19.
5. Yu W, Maru F, Edner M, et al. (2004) Spinal cord stimulation for refractory angina pectoris: a retrospective analysis of efficacy and cost-benefit. Coronary Artery Disease; 15: 31–37.
6. Ubbink DT, Vermeulen H, Spincemaille GHJJ, et al. (2004) Systematic review and meta-analysis of controlled trials assessing spinal cord stimulation for inoperable critical leg ischaemia. Br J Surg; 91: 948–955.

Information on this site should not be used as a substitute for talking with your doctor. Always talk with your doctor about diagnosis and treatment information.

Last updated: 25 Oct 2011

Section Navigation

Additional information

Contact Us

Medtronic Limited
Building 9
Croxley Green Business Park
Hatters Lane
Watford, Hertfordshire
WD18 8WW
Medtronic
work Tel. +44 (0)1923 212213
work

Fax +44 (0)1923 241004

United Kingdom